Indomethacin and nordihydroguaiaretic acid inhibition of amyloid β protein (25–35) activation of phospholipases A2 and D of LA-N-2 cells
- 1 January 1997
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 222 (1) , 5-8
- https://doi.org/10.1016/s0304-3940(97)13327-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- IL-1 and anti-inflammatory drugs modulate A β cytotoxicity in PC12 cellsBrain Research, 1996
- Role of microglia in senile plaque formationNeurobiology of Aging, 1995
- The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseasesBrain Research Reviews, 1995
- Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brainNeurochemistry International, 1995
- Amyloid beta protein (25–35) stimulation of phospholipases A, C and D activities of LA‐N‐2 cellsFEBS Letters, 1995
- Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulationBrain Research, 1994
- Exposure toN-methyl-d-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytesBrain Research, 1990
- Anti-inflammatory drugs and Alzheimer diseaseThe Lancet, 1990
- Enzymatic activites during differentiation of the human neuroblastoma cells, LA‐N‐1 and LA‐N‐2Journal of Neuroscience Research, 1990
- The formation of [3H]inositol phosphates in human platelets by palmitoyl lysophosphatidic acid is blocked by indomethacinBiochemical and Biophysical Research Communications, 1985